Cite
HARVARD Citation
Rudman, S. et al. (n.d.). Risk of prostate cancer‐specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence. BJU international. pp. 919-926. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rudman, S. et al. (n.d.). Risk of prostate cancer‐specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence. BJU international. pp. 919-926. [Online].